BrettAndrewKingMDPhD

PubMed

• The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
  , Anthony Moussa, Michaela Bennett, Dmitri Wall, Nekma Meah, Katherine York, Laita Bokhari, Leila Asfour, Huw Rees, Leonardo Spagnol Abraham, Daniel Asz-Sigall, Fitnat...> ;JAMA Dermatology. 2024 Mar 1
• Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
  Tziotzios, C., Rudnicka, L., Joly, P., Gooderham, M., Sinclair, R., Paul, C., Gong, Y., Anway, S., Tran, H., Wolk, R., Zwillich, S., Lejeune, A., King, B., Soung, J., ...> ;American Journal of Clinical Dermatology. 2024 Mar 1
• Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.
  Maryanne M Senna, Ohsang Kwon, Bianca M Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King> ;Dermatology and Therapy. 2023 Dec 1
• 1 citations
  When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase I...
  Brett King, Jerry Shapiro, Manabu Ohyama, Alexander Egeberg, Bianca Maria Piraccini, Brittany Craiglow, Rodney Sinclair, Yun-Fei Chen, Wen-Shuo Wu, Yuxin Ding, Najwa S...> ;The British Journal of Dermatology. 2023 Nov 16
• 4 citations
  Janus kinase inhibitors for alopecia areata.
  Brett A King, Brittany G Craiglow> ;Journal of the American Academy of Dermatology. 2023 Aug 1
• 1 citations
  A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata.
  Brett King, Xingqi Zhang, Walter Gubelin Harcha, Jacek C Szepietowski, Jerry Shapiro, Charles Lynde, Natasha A Mesinkovska, Samuel H Zwillich, Lynne Napatalung, Dalia ...> ;Immunotherapy. 2023 Oct 1
• 2 citations
  Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise.
  Thomas, C., Waters, M., Dobry, A., Le, S., Shinkai, K., Beachkofsky, T., Davis, M., Dominguez, A., Kroshinsky, D., Markova, A., Micheletti, R., Mostaghimi, A., Pasieka...> ;JAMA Dermatology. 2023 Jul 1
• Overview of alopecia areata for managed care and payer stakeholders in the United States.
  Brett King, Edmund Pezalla, Selwyn Fung, Helen Tran, Jeffrey A Bourret, Kathleen Peeples-Lamirande, Liza Takiya, Lynne Napatalung> ;Journal of Managed Care & Specialty Pharmacy. 2023 Jul 1
• 19 citations
  Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
  Brett King, Xingqi Zhang, Walter Gubelin Harcha, Jacek C Szepietowski, Jerry Shapiro, Charles Lynde, Natasha A Mesinkovska, Samuel H Zwillich, Lynne Napatalung, Dalia ...> ;Lancet. 2023 May 6
• 19 citations
  Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
  Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, Taisuke Ito, Yves Dutronc, Chen-Yen Lin, Guanglei Yu, Chiara Chiasserini, Jill McCollam, Wen-Shuo Wu, Brett King> ;American Journal of Clinical Dermatology. 2023 May 1
• 19 citations
  Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
  Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Gwang-Seong Choi, Ulrike Blume-Peytavi, Thierry Passeron, Katrin Holzwarth, Yves Dutronc, Jill McC...> ;The British Journal of Dermatology. 2023 Feb 10
• 2 citations
  Inhibition of T-cell activity in alopecia areata: recent developments and new directions.
  Thierry Passeron, Julien Seneschal, Martin Steinhoff, Manabu Ohyama, Desmond J Tobin, Aaron Winkler, Jean-Baptiste Telliez, David Martin, Alexandre Lejeune, Brett King...> ;Frontiers in Immunology. 2023 Jan 1
• 22 citations
  Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
  Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, Lori Ann Cox, Anindita Banerjee, George Han, Iltefat Hamzavi, Anand K Ganesan, Mauro Picardo, Diamant Thaçi, John E Harri...> ;Journal of the American Academy of Dermatology. 2023 Feb 1
• Erythrodermic scabies in an immunocompetent patient.
  Ronan Talty, Goran Micevic, William Damsky, Brett A King> ;JAAD Case Reports. 2022 Nov 1
• 5 citations
  Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial.
  Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Linda Zhu, Hua Zhu, Lori Ann Cox, Michael S Vincent, Rodney Sinclair> ;JID Innovations. 2022 Nov 1
• 1 citations
  Sisaipho alopecia areata treated with tofacitinib and oral minoxidil.
  Ronan Talty, William Damsky, Brett King> ;JAAD Case Reports. 2022 Nov 1
• 9 citations
  The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
  Eric L Simpson, Robert Bissonnette, Amy S Paller, Brett King, Jonathan I Silverberg, Kristian Reich, Jacob P Thyssen, Helen Doll, Luna Sun, Amy M DeLozier, Fabio P Nun...> ;The British Journal of Dermatology. 2022 Oct 1
• 31 citations
  Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.
  Brett King, Natasha Mesinkovska, Paradi Mirmirani, Suzanne Bruce, Steve Kempers, Emma Guttman-Yassky, Janet L Roberts, Amy McMichael, Maria Colavincenzo, Colleen Hamil...> ;Journal of the American Academy of Dermatology. 2022 Aug 1
• 1 citations
  A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures.
  Helen Kitchen, Kavita Gandhi, Chloe Carmichael, Kathleen W Wyrwich, Tatjana Lukic, Tamara Al-Zubeidi, Chris Marshall, Hannah Pegram, Sharon King, Brett King> ;Dermatology and Therapy. 2022 Aug 1
• 1 citations
  Reply to: "Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021,...
  Brett A King, Brittany G Craiglow> ;Journal of the American Academy of Dermatology. 2022 Aug 1
• 11 citations
  Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clin...
  Elena Peeva, Emma Guttman-Yassky, Anindita Banerjee, Rodney Sinclair, Lori Ann Cox, Linda Zhu, Hua Zhu, Michael Vincent, Brett King> ;Journal of the American Academy of Dermatology. 2022 Aug 1
• 3 citations
  Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
  Kathleen W Wyrwich, Helen Kitchen, Sarah Knight, Natalie V J Aldhouse, Jake Macey, Natasha Mesinkovska, Justin M Ko, Brett A King> ;Quality of Life Research. 2023 May 1
• 8 citations
  Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.
  Brett A King, Maryanne M Senna, Manabu Ohyama, Antonella Tosti, Rodney D Sinclair, Susan Ball, Justin M Ko, Marc Glashofer, Rodrigo Pirmez, Jerry Shapiro> ;Dermatology and Therapy. 2022 Apr 1
• 28 citations
  Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
  Emma Guttman-Yassky, Ana B. Pavel, Ning Zhang, Ester Del Duca, Yeriel Estrada, Brett A. King, Anindita Banerjee, Christopher Banfield, Lori Ann Cox, Martin E. Dowty, K...> ;The Journal of Allergy and Clinical Immunology. 2021 Dec 1
• 5 citations
  A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome (PRO) measures.
  Jake Macey, Helen Kitchen, Natalie V. J. Aldhouse, Emily Edson-Heredia, Russel Burge, A Prakash, Brett A. King, Natasha Atanaskova Mesinkovska> ;The British Journal of Dermatology. 2021 Nov 22
• Join now to see all

Journal Articles

• Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management  
  Brett A King, Ian W Tattersall, Paul A Gaudio, JAMA
• Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis  
  Craiglow BG, King BA, J Invest Dermatol, 1/1/2014
• Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate  
  Levy LL, Urban J, King BA, J Am Acad Dermatol, 1/1/2015
• Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy  
  Craiglow BG, King BA, JAMA Dermatol, 1/1/2015
• Psychophysical measurements of itch and nociceptive sensations in an experimental model of allergic contact dermatitis  
  Pall PS, Hurwitz OE, King BA, LaMotte RH, J Pain, 1/1/2015
• Purpuric Lesions on Acral Sites Type I cryoglobulinemia associated with multiple myeloma  
  Fraser Gibson J, Leventhal JS, King B, JAMA Dermatol, 1/1/2015
• 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination t...  
  Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Mavera..., J Am Acad Dermatol, 1/1/2015
• Divalproex sodium: A potential therapy for scleroderma digital ulcers  
  Urban JR, King B, J Am Acad Dermatol, 1/1/2015
• When erythema ab igne warrants an evaluation for internal malignancy  
  Bunick CG, Ibrahim O, King BA, Int J Dermatol, 1/1/2014
• Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines  
  Patel F, Wilken R, Burrall B, Martinez S, Wells V, King B, Maverakis E, Dermatol Online J, 1/1/2014
• Capillary malformation--arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management  
  Orme CM, Boyden LM, Choate KA, Antaya RJ, King BA, Pediatr Dermatol, 1/1/2013
• Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection  
  Lott JP, Liu K, Landry ML, Nix WA, Oberste MS, Bolognia J, King B, J Am Acad Dermatol, 1/1/2013
• An unusual clinical and histologic presentation of disseminated cutaneous histoplasmosis  
  Srivastava B, King B, Galan A, J Am Acad Dermatol, 1/1/2011
• Palifermin-associated papular eruption  
  King B, Knopp E, Galan A, Nuovo G, Tigelaar R, McNiff J, Arch Dermatol, 1/1/2009
• Join now to see all

Lectures

• Alopecia: Work-up and Treatment 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
• Controversies in Dermatology: Stevens-Johnson Syndrome/TEN 
  Miami Beach, FL - 1/1/2010
• TEN 2011 
  New York, NY - 1/1/2010
• Excited State Dynamics in Green-, Blue-, and Red-fluorescent Proteins: Multiple States and Proton Transfer 
  New Brunswick, NY - 1/1/1997
• Join now to see all